Total Funding
34
65
Total FundingSeries B raised
Growth Score 34 in past quarter
-2 pts
Heat Score 65 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
44483
At HALO Diagnostics, our focus is saving lives through early detection with precision diagnostics, preventing and conquering diseases.
- Aram Compeau: CTO
Michael Uhl: Co-Founder, Chief Executive Officer
About the Company
At HALO Diagnostics (HALO Dx), we recognize every patient is unique. Our focus is early detection and precision-focused healthcare, preventing, and conquering diseases that have a geometric impact on patient outcomes. We accomplish this with a personalized diagnostic ensemble including advanced imaging, genomics, non-invasive liquid biomarker
tests, and community-based data at scale combined with deep learning algorithms. By optimizing these solutions under the HALO Dx platform, we provide precise, actionable results to enable life-changing treatments by physicians for their patients.